コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ens (e.g. Helicobacter pylori, C. jejuni and Treponema pallidum).
2 e asymptomatic when they are reinfected with Treponema pallidum.
3 lopment following intradermal challenge with Treponema pallidum.
4 hesin Tp0751 within the spirochete bacterium Treponema pallidum.
5 e of the related syphilis-causing spirochete Treponema pallidum.
6 disease caused by the spirochetal bacterium Treponema pallidum.
7 ermini of the 17- and 47-kDa lipoproteins of Treponema pallidum.
8 from the emergence of phenotypic variants of Treponema pallidum.
9 se of humans caused by spirochetal bacterium Treponema pallidum.
10 lated oral spirochetes (PROS) are related to Treponema pallidum.
11 ctivation by motile Borrelia burgdorferi and Treponema pallidum.
12 or by identification of the causative agent, Treponema pallidum.
13 n identified previously in OM fractions from Treponema pallidum.
14 nd characterized in Treponema phagedenis and Treponema pallidum.
15 vage site, and has 26% identity with TmpC of Treponema pallidum.
16 bacterial infection caused by the bacterium Treponema pallidum.
17 mydia trachomatis, Neisseria gonorrhoeae, or Treponema pallidum.
18 n (TMA) assay for the detection of rRNA from Treponema pallidum.
19 is a sexuality transmitted disease caused by Treponema pallidum.
20 eraction datasets of Helicobacter pylori and Treponema pallidum.
21 philis is caused by the spirochetal pathogen Treponema pallidum.
22 ) for herpes simplex virus, and 27 (19%) for Treponema pallidum; 12 (8%) were positive for > 1 organi
23 Neurosyphilis was defined as detection of Treponema pallidum 16S RNA in CSF or CSF white blood cel
24 Syphilis is an infectious disease caused by Treponema pallidum, a gram-negative, spirochete bacteriu
26 The Tp34 (TP0971) membrane lipoprotein of Treponema pallidum, an obligate human pathogen and the a
29 is increasing evidence that lipoproteins of Treponema pallidum and Borrelia burgdorferi are key infl
31 spirochetes including the syphilis bacterium Treponema pallidum and Lyme disease pathogen Borrelia bu
34 of the organisms Caenorhabditis elegans and Treponema pallidum and to differ by one residue from PEP
36 me disease (Borrelia burgdorferi), syphilis (Treponema pallidum) and leptospirosis (Leptospira interr
37 etected nucleic acid target (tpp47 gene from Treponema pallidum) and nitrite ions in an aqueous sampl
38 r antibodies to herpes simplex virus type 2, Treponema pallidum, and hepatitis B, tests for hepatitis
39 ion of DNA targets from Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus (HSV) types
40 ction (M-PCR) assay for Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus (HSV) was c
41 eaction assay to detect Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus (HSV); sera
42 al ulcer disease (GUD), Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus, was used t
44 eins/lipopeptides from Borrelia burgdorferi, Treponema pallidum, and Mycoplasma fermentans activated
47 t [FTA-ABS], microhemagglutination assay for Treponema pallidum antibodies [MHA-TP], Treponema pallid
49 d electronic reader for detection of HIV and Treponema pallidum antibodies in 450 previously characte
51 mology with the sequences of E. coli Dps and Treponema pallidum antigen TpF1 or 4D, proteins which as
52 rex Diagnostics) that uses three recombinant Treponema pallidum antigens (TpN15, TpN17, and TpN47) an
53 ively detects IgG and IgM antibodies against Treponema pallidum antigens in human serum and plasma.
54 lopment of the T-cell response to a panel of Treponema pallidum antigens over the course of syphilis
57 ly detected ulcers were tested for HSV-2 and Treponema pallidum by polymerase chain reaction (PCR).
66 rase chain reaction (PCR) was used to detect Treponema pallidum DNA in cerebrospinal fluid (CSF) from
67 e used real-time quantitative PCR to measure Treponema pallidum DNA levels in rabbits infected intrat
72 e evaluated a molecular subtyping system for Treponema pallidum for its ability to differentiate betw
76 the United States, yet little is known about Treponema pallidum genomic epidemiology within American
77 obtained with standard laboratory tests (the Treponema pallidum haemagglutination assay [TPHA] and th
78 polymerase chain reaction (M-PCR) to detect Treponema pallidum, Haemophilus ducreyi, and herpes simp
81 varied genome sizes (Mycoplasma pneumoniae, Treponema pallidum, Helicobacter pylori, Campylobacter j
82 tion assay (CSF-TPPA) is sensitive and a CSF Treponema pallidum hemagglutination assay (CSF-TPHA) tit
83 pid plasma reagin [RPR] titer > or = 1:8 and Treponema pallidum hemagglutination assay [TPHA]/fluores
84 asma reagin titer > or = 1 :8 and a positive Treponema pallidum hemagglutination assay or indirect fl
85 a focus on alternative agglutination assays (Treponema pallidum hemagglutination assays, TPHAs) as th
86 munoassay for the detection of HIV-1, HIV-2, Treponema pallidum, hepatitis B virus (HBV), hepatitis C
87 unts, and serologic assays for antibodies to Treponema pallidum, herpes simplex virus, and hepatitis
88 be a false-positive reaction by nonreactive Treponema pallidum immobilization and fluorescent trepon
89 polymerase chain reaction (PCR) testing for Treponema pallidum in cerebrospinal fluid (CSF) samples.
90 sensitive and specific PCR method to detect Treponema pallidum in clinical specimens was developed.
93 hilis and invasion of cerebrospinal fluid by Treponema pallidum in patients with human immunodeficien
94 ons of syphilis and the invasive behavior of Treponema pallidum in tissue culture systems reflect the
98 d to examine mechanisms that likely underlie Treponema pallidum-induced immune cell activation and co
107 e genome of the etiologic agent of syphilis, Treponema pallidum, is compact and devoid of many metabo
108 In syphilis research, the Nichols strain of Treponema pallidum, isolated in 1912, has been the most
111 that this protein shares similarity with the Treponema pallidum LRR (LRR(TP)) family of proteins and
112 rrelia burgdorferi and by B. burgdorferi and Treponema pallidum lysates but were poorly activated by
114 followed by microhemagluttination assay for Treponema pallidum (MHA-TP) testing of RPR-reactive sera
115 compared the microhemagglutination assay for Treponema pallidum (MHA-TP), a treponemal test, with two
118 s were used: a nonimmune group infected with Treponema pallidum (NI/TP), a nonimmune group injected w
119 ettsia rickettsii, Chlamydia group positive, Treponema pallidum, Orientia tsutsugamushi, Fransciscell
120 TroA (Tromp1) was initially reported to be a Treponema pallidum outer membrane protein with porin-lik
125 with two other treponemal tests, the Serodia Treponema pallidum particle agglutination (TP-PA) assay
126 chemiluminescence immunoassay (CLIA), and a Treponema pallidum particle agglutination (TP-PA) test.
127 ther tested by rapid plasma reagin (RPR) and Treponema pallidum particle agglutination (TP.PA) testin
128 lis has been impacted by a withdrawal of the Treponema pallidum particle agglutination (TPPA) assay f
130 flex testing with rapid plasma reagin (RPR), Treponema pallidum particle agglutination (TPPA), and fl
131 [FTA] assay [Zeus Scientific, Raritan, NJ], Treponema pallidum particle agglutination [TP-PA; Fujire
132 and Trep-Sure EIA) and three manual assays (Treponema pallidum particle agglutination [TP-PA], fluor
133 ed data suggest that the cerebrospinal fluid Treponema pallidum particle agglutination assay (CSF-TPP
134 al serology underwent reflexive testing with Treponema pallidum particle agglutination assay (TP-PA)
135 , RPR-negative serology were tested with the Treponema pallidum particle agglutination assay (TP-PA)
136 LIA (line immunoassay); (5) LIAISON CIA; (6) Treponema pallidum particle agglutination assay (TPPA);
137 for Treponema pallidum antibodies [MHA-TP], Treponema pallidum particle agglutination assay [TP-PA])
138 sly evaluated using the rapid plasma reagin, Treponema pallidum particle agglutination, and chemilumi
139 ative rapid plasma reagin (RPR) test and the Treponema pallidum passive particle agglutination (TP-PA
140 Western blot analysis using antisera to Treponema pallidum PF proteins along with N-terminal ami
142 complete genomes of Borrelia burgdorferi and Treponema pallidum provides a number of insights into ev
144 e have previously observed that while native Treponema pallidum rare outer membrane protein 1 (Tromp1
148 aggregates the low-density membrane-spanning Treponema pallidum rare outer membrane proteins (TROMPs)
150 logical testing and an experimental 23S rRNA Treponema pallidum real-time transcription-mediated ampl
151 la, as well as the parental ortholog for the Treponema pallidum repeat (Tpr) family in the syphilis s
154 ts immunized with the Seattle Nichols strain Treponema pallidum repeat protein K (TprK) were previous
157 anscription-mediated amplification assay for Treponema pallidum (RUO T. pallidum TMA) yields instance
159 of the spirochaetes Borrelia burgdorferi and Treponema pallidum show strong strand-specific skews in
161 suggest the induction of local and systemic Treponema pallidum-specific CD4+ T-cell responses to T.
162 creening tests (antilipoidal antibodies) and Treponema pallidum-specific tests (anti-T. pallidum anti
165 onfers macrolide resistance is present in >1 Treponema pallidum strain, 58 isolates collected between
166 techniques that allow the differentiation of Treponema pallidum strains on the basis of two variable
169 ous bacterial PCR was initially positive for Treponema pallidum, subsequent PCR was negative prior to
171 n lesions or presence of ulcers negative for Treponema pallidum subsp pertenue on PCR, and active yaw
177 of the 15-kDa gene have been determined for Treponema pallidum subsp. pallidum (Nichols and Bal-3 st
178 tive transport related operon (tro) locus of Treponema pallidum subsp. pallidum (Nichols strain) (Tp)
179 transcript levels in the syphilis spirochete Treponema pallidum subsp. pallidum (Nichols) isolated fr
180 Transcriptional analysis of the tpr genes in Treponema pallidum subsp. pallidum (referred to here as
181 s, is morphologically indistinguishable from Treponema pallidum subsp. pallidum (T. pallidum), the hu
183 this bacterial infection, which is caused by Treponema pallidum subsp. pallidum (TPA), has been re-em
184 s in Cuba prompted us to map the circulating Treponema pallidum subsp. pallidum allelic profiles in t
187 ons have demonstrated that immunization with Treponema pallidum subsp. pallidum glycerophosphodiester
190 and expression of the gene encoding a 28-kDa Treponema pallidum subsp. pallidum rare outer membrane p
191 and sequencing of the gene encoding a 31-kDa Treponema pallidum subsp. pallidum rare outer membrane p
192 908 of the 1,039 proteins in the proteome of Treponema pallidum subsp. pallidum using a protein array
193 ly mapping the 47-kDa lipoprotein (Tpp47) of Treponema pallidum subsp. pallidum using an overlapping
194 ction of the predicted lipoprotein TP0136 of Treponema pallidum subsp. pallidum were investigated bas
195 ent Tpr proteins in the syphilis spirochete, Treponema pallidum subsp. pallidum, may have important i
196 syphilis, caused by the spirochete bacterium Treponema pallidum subsp. pallidum, remains a public hea
202 n occurs in surface-exposed proteins, and in Treponema pallidum subsp. pallidum, the syphilis agent,
203 The tprK gene in the syphilis spirochete, Treponema pallidum subsp. pallidum, undergoes antigenic
206 ribing the use of DNA sequencing to identify Treponema pallidum subsp. pertenue-specific sequences in
210 cy of 18 antibiotics from several classes on Treponema pallidum subspecies pallidum (T pallidum), the
214 s a sexually transmitted infection caused by Treponema pallidum subspecies pallidum and may lead to s
215 thogen-related oral spirochetes (PROS, using Treponema pallidum subspecies pallidum monoclonal antibo
223 disease (Borrelia burgdorferi) and syphilis (Treponema pallidum) swim through viscous fluids, such as
224 multaneously for multiple antigens of HIV-1, Treponema pallidum (syphilis), and hepatitis C virus (HC
225 eisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum (syphilis), herpes simplex virus 2, a
227 purified outer membrane vesicles (OMV) from Treponema pallidum (T.p.) could elicit Abs capable of ki
228 ns are caused by a family of closely related Treponema pallidum that give rise to the diseases yaws,
229 s is a chronic bacterial infection caused by Treponema pallidum that is endemic in low-income countri
232 Here we tested the effect of 405 nm light on Treponema pallidum, the bacterium that causes syphilis.
233 mography (cryo-ET) was utilized to visualize Treponema pallidum, the causative agent of syphilis, at
238 rformed, targeting Chlamydia trachomatis and Treponema pallidum, the causative agents of Chlamydia an
239 Insights into the genomic adaptive traits of Treponema pallidum, the causative bacterium of syphilis,
247 est for the detection of human antibodies to Treponema pallidum." The Syphilis Health Check is the on
249 in this cluster are most similar to those of Treponema pallidum (Tp) and Bacillus subtilis (Bs).
250 reading frame (cheX) that is homologous with Treponema pallidum (Tp) and Borrelia burgdorferi (Bb) ch
251 dy, we found that in Tanzania infection with Treponema pallidum (TP) subsp. pertenue (TPE) is present
252 DFM) and polymerase chain reaction (PCR) for Treponema pallidum (TP), and by PCR for Haemophilus ducr
253 ittle is known about the mechanisms by which Treponema pallidum (Tp), the causative agent of syphilis
254 nd composition of the outer membrane (OM) of Treponema pallidum (Tp), the noncultivable agent of vene
255 in reaction (PCR) targeting the polA gene of Treponema pallidum (TP-PCR), we tested the following stu
257 he antigenicity of the 15-kDa lipoprotein of Treponema pallidum (Tpp15 or TpN15) was comprehensively
258 Two new tprD alleles have been identified in Treponema pallidum: tprD2 is found in 7 of 12 T. pallidu
266 A serum sample containing antibody against Treponema pallidum was reported as positive by 70% of th
268 d-type fliG genes from T. denticola and from Treponema pallidum were cloned into this expression plas